Key Segments:
By Type
-
Postpartum Blues
-
Postpartum Anxiety
-
Postpartum Obsessive-Compulsive Disorder (OCD)
-
Postpartum Post-Traumatic Stress Disorder (PTSD)
-
Postpartum Panic Disorder
-
Postpartum Psychosis
By Treatment
-
Pharmacotherapy
-
Hormonal Therapy
-
Others
By Administration
-
Parenteral
-
Oral
-
Others
By Distribution Channel
-
Hospital Pharmacy
-
Retail Pharmacy
-
Others (online pharmacy)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America led in 2025 with 40.6% share, due to advanced healthcare, early adoption of new treatments, strong insurance coverage, and high maternal mental health awareness.
The Postpartum Anxiety segment dominated with 30.86% market share in 2025, supported by high clinical visibility, screening initiatives, and overlapping pharmacological treatments.
Growth is driven by increasing maternal mental health awareness, early diagnosis, rising clinical adoption of neurosteroid-based therapies, and expanding digital health platforms.
In 2025, the Postpartum Depression Drugs Market was valued at USD 959.62 million, reflecting growing demand for pharmacological and novel therapies.
The market is projected to grow at a CAGR of 9.45% from 2026 to 2033, driven by rising awareness and increased treatment adoption globally.